Autoimmune and Autoinflammatory Genetics Study
NCT06004349 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500
Last updated 2025-07-09
Summary
This is an exploratory natural history protocol that will enroll patients with known genetic diseases, such as VEXAS syndrome, or as yet undiagnosed disorders of inflammation with the goal of improving our understanding of disease processes. Blood, saliva, hair, nail, or buccal samples may be collected for genetic analysis, blood samples will be obtained for immunologic and other functional studies, and a small number of subjects may undergo skin biopsy.
Conditions
- VEXAS Syndome
- Autoinflammatory Disease
- Autoimmune Disease
- Rheumatic Disease
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
David Beck, MD, PhD · NYU Langone Health
Eligibility
- Min Age
- 1 Month
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-04-15
- Primary Completion
- 2032-04-05
- Completion
- 2032-04-05
Countries
- United States
Study Locations
More Related Trials
-
Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis
NCT02169219 ·Status: COMPLETED ·Phase: PHASE4
-
PRediction of DIverse Glucocorticoids ToxIcity OUtcomeS
NCT04664465 ·Status: RECRUITING
-
Steroids and Methotrexate to Treat Systemic Vasculitis
NCT00001256 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial to Evaluate Safety and Efficacy of CCX168 in ANCA-Associated Vasculitis
NCT02222155 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of ACZ885 in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease
NCT00685373 ·Status: COMPLETED ·Phase: PHASE3
-
Vasculitis Pregnancy Registry
NCT02593565 ·Status: RECRUITING
-
Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Still'S-like Diseases, and Other Undifferentiated Autoinflammatory Diseases)
NCT02974595 ·Status: RECRUITING
-
Journey of Patients With Vasculitis From First Symptom to Diagnosis
NCT03410290 ·Status: COMPLETED
-
Defining Immune Tolerance in ANCA-associated Vasculitis (AAV)
NCT01934504 ·Status: TERMINATED
-
PRO Development for ANCA Associated Vasculitis
NCT01729624 ·Status: UNKNOWN
-
Phenotypic Expressions in a French Pseudoxanthoma-Elasticum Cohort
NCT01446380 ·Status: UNKNOWN
-
Tocilizumab and Tofacitinib in the Treatment of Vascular Behçet's Syndrome
NCT05845723 ·Status: RECRUITING ·Phase: PHASE2
-
Evaluation of Glucocorticoids Plus Rituximab in Patients with Newly-Diagnosed or Relapsing IgA Vasculitis
NCT05329090 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis
NCT00104299 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Clinical Transcriptomics in Systemic Vasculitis (CUTIS)
NCT03004326 ·Status: RECRUITING
-
Reproductive Health in Men and Women With Vasculitis
NCT02176070 ·Status: COMPLETED
-
Longitudinal Protocol for Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis
NCT00315393 ·Status: COMPLETED
-
Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis
NCT00987389 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Vasculitis on Employment and Income
NCT02476292 ·Status: COMPLETED
-
Genetic Susceptibility Factors for Candidemia.
NCT02841501 ·Status: COMPLETED
-
Intravenous Immunoglobulin After Relapse in Vasculitis
NCT00307658 ·Status: TERMINATED ·Phase: PHASE3
-
Study of NM8074 in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV)
NCT06226662 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study to Evaluate the Safety and Efficacy of CCX168 in Subjects With ANCA-Associated Vasculitis
NCT01363388 ·Status: COMPLETED ·Phase: PHASE2
-
The Longitudinal Evaluation of Autoimmune Pulmonary Alveolar Proteinosis
NCT03531996 ·Status: COMPLETED
-
Educational Needs of Patients With Systemic Vasculitis
NCT02190929 ·Status: COMPLETED